Abstract
With the aim of describing an unselected series of acute myeloid leukaemias (AML) in adults, patients diagnosed 1987–1992 in the Örebro region of central Sweden were reviewed by investigating hospital records. By utilizing: (1) The Swedish Cancer Registry, (2) The Cause of Death Registry, (3) listings of pathology bone marrow reports and (4) listings of inpatient discharge diagnoses, we attempted to find all patients. Among secondary AML, only blast-crises of CML were excluded. A total of 214 cases of AML with a median age of 69.5 years were verified corresponding to a mean yearly incidence in adults of 5.4/100 000. Of all patients, 56% had received ‘high-dose’ induction treatment, 28% ‘low-dose’ treatment and 16% no cytostatic treatment. Median survival for all patients was 5.8 months and the probability of survival at 5 years was 9.3%. The 120 ‘high-dose’ treated patients had a total CR rate of 67%, median CR duration 10.1 months and median survival 11.4 months. Age, LDH and kidney function were found to be independent prognostic variables for survival. The inclusion of patients unreferred from district hospitals makes this study unique as an example of unselected AML. © 2000 Cancer Research Campaign
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Bassan R, Buelli M, Viero P, Minotti C and Barbui T (1992) The management of acute myelogenous leukemia in the elderly: ten year experience in 118 patients. Hematol Oncol 10: 251–260
Baudard M, Marie JP, Cadiou M, Viguié F and Zittoun R (1994) Acute myelogenous leukaemia in the elderly: retrospective study of 235 consecutive patients. Br J Haematol 86: 82–91
Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR and Sultan C (1985) Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French–American–British Cooperative Group. Ann Int Med 103: 620–625
Bernard P, Reiffers J, Lacombe F, Dachary D, Boisseau M and Broustet A (1984) A stage classification for prognosis in adult acute myelogenous leukemia based upon patients' age, bone marrow karyotype and clinical features. Scand J Haematol 32: 429–440
Boros L, Chuang C, Butler FO and Bennett JM (1985) Leukemia in Rochester (NY). A 17-year experience with an analysis of the role of cooperative group (ECOG) participation. Cancer 56: 2161–2169
Brincker H (1985) Estimate of overall treatment results in acute non-lymphocytic leukemia based on age-specific rates of incidence and of complete remission. Cancer Treat Rep 69: 5–11
Büchner T and Heinecke A (1996) The role of prognostic factors in acute myeloid leukemia. Leukemia 10: 28–29
DeLima M, Ghaddar H, Pierce S and Estey E (1996) Treatment of newly-diagnosed acute myelogenous leukaemia in patients aged 80 years and above. Br J Haematol 93: 89–95
Dutcher JP, Schiffer CA and Wiernik PH (1987) Hyperleukocytosis in adult acute nonlymphocytic leukemia: impact on remission rate and duration, and survival. J Clin Oncol 5: 1364–1372
Estey E, Smith TL, Keating MJ, McCredie KB, Gehan EA and Freireich EJ (1989) Prediction of survival during induction therapy in patients with newly diagnosed acute myeloblastic leukemia. Leukemia 3: 257–263
Fenaux P, Preudhomme C, Lai JL, Morel P, Beuscart R and Bauters F (1989) Cytogenetics and their prognostic value in de novo acute myeloid leukemia: a report on 283 cases. Br J Haematol 73: 61–67
Ferrara F and Mirto S (1996) Serum LDH value as a predictor of clinical outcome in acute myelogenous leukaemia of the elderly. Br J Haematol 92: 627–631
Ferrara F, Mirto S, Zagonel V and Pinto A (1998) Acute myeloid leukemia in the elderly: a critical review of therapeutic approaches and appraisal of results of therapy. Leuk Lymphoma 29: 375–382
Hoff PM, Pierce S and Estey E (1997) Comparison of acute myeloid leukemia patients at MD Anderson: 1982–1986 vs 1992–1996. Leukemia 11: 1997–1998
Johnson PRE, Hunt LP and Liu Yin JA (1993) Prognostic factors in elderly patients with acute myeloid leukaemia: development of a model to predict survival. Br J Haematol 85: 300–306
Johnson PRE, Ryder WD and Liu Yin JA (1995) Validation of a model to predict survival in elderly patients with acute myeloid leukaemia. Br J Haematol 90: 954–956
Löwenberg B (1996) Treatment of the elderly patient with acute myeloid leukaemia. Baillières Clin Haematol 9: 147–159
Mattsson B and Wallgren A (1984) Completeness of the Swedish Cancer Register. Acta Radiol Oncol 23: 305–313
McKinney PA, Alexander F, Cartwright RA and Ricketts TJ (1989) The Leukaemia Research Fund Data Collection Survey: the incidence and geographical distribution of acute myeloid leukemia. Leukemia 3: 875–879
Öst Å, Lindström P, Christensson B, Gyllenhammar H and Engstedt L (1984) Acute leukaemia in a defined geographic area – incidence, clinical history and prognosis. Scand J Haematol 33: 160–170
Proctor SJ, Taylor PRA, Stark A, Carey PJ, Bown N, Hamilton PJ and Reid MM (1995) Evaluation of the impact of allogenic transplant in first remission on an unselected population of patients with acute myeloid leukaemia aged 15–55 years. Leukemia 9: 1246–1251
Rowe JM and Liesveld JL (1996) Treatment and prognostic factors in acute myeloid leukaemia. Baillières Clin Haematol 9: 87–105
Statistics Sweden (1987–1992) DEMOPAK
Taylor PRA, Reid MM, Stark AN, Bown N, Hamilton PJ and Proctor SJ (1995) De novo acute myeloid leukaemia in patients over 55-years-old: a population-based study of incidence, treatment and outcome. Leukemia 9: 231–237
The Toronto Leukemia Study Group (1986) Results of chemotherapy for unselected patients with acute myeloblastic leukaemia: effect of exclusions on interpretation of results. Lancet i: 786–788
Wahlin A, Hörnsten P and Jonsson H (1991) Remission rate and survival in acute myeloid leukemia: impact of selection and chemotherapy. Eur J Haematol 46: 240–247
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Åström, M., Bodin, L., Nilsson, I. et al. Treatment, long-term outcome and prognostic variables in 214 unselected AML patients in Sweden. Br J Cancer 82, 1387–1392 (2000). https://doi.org/10.1054/bjoc.1999.1123
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.1999.1123